Back to search

Cardiatec Biosciences Ltd

13634184

active
Private Limited Company
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Going concern doubt noted in accounts (-10)

Details

KETTON SUITE THE KING CENTRE, MAIN ROAD, OAKHAM, LE15 7WD
Incorporated 21/09/2021

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Raphael Peralta

director · Since 21/09/2021

CEO

BRITISH · UNITED KINGDOM · Age 27

Ms Thelma Zablocki

director · Since 20/05/2022

COO

FRENCH · PORTUGAL · Age 27

Mr Niall John Santamaria

director · Since 24/06/2022

DIRECTOR

BRITISH · SCOTLAND · Age 42

Also on 1 other board

Todd Barrett Kimmel

director · Since 07/06/2024

VENTURE CAPITAL

AMERICAN · UNITED STATES · Age 51

Persons with Significant Control

Former PSCs

Raphael Peralta

Ceased 07/06/2024

Ms Thelma Zablocki

Ceased 29/03/2024

Mr Namshik Han

Ceased 29/03/2024

CompanyRankvs 344+ SIC 72110 peers
67

Financial strength96th percentile among SIC peers · 24/25
Employees89th percentile among SIC peers · 13/15
LiquidityCurrent ratio 18.55× · 20/20
Longevity5 years trading (max 15) · 5/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Bio - Diagnostics Limited
89
9Biointeractions Limited
89
10Ams Advanced Medical Services Limited
89
344Cardiatec Biosciences Ltd
76
How is this score calculated?
Financial strength24/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees13/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity5/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

Act 2006. The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £. 2.2. Going Concern Disclosure The directors have not identified any material uncertainties related to events or conditions that may cast significant doubt about the company's ability to continue as a going

Key FinancialsYear ending 31/12/2025

Net Worth

£3.5M

Balance sheet strength

Cash

£3.2M

Cash in the bank

Net Current Assets

£3.5M

Working capital

Current Assets

£3.7M

Current Liabilities

£199k

Fixed Assets

£9k

Debtors

£486k

7avg. employees

Tax at Year End(2023)

Corp tax-£115k

Balance Sheet

Intangible assets£4k
Assets less current liabilities£3.5M
Signed by Ms Thelma Zablocki 17 February 2026Prepared with Acorah Software Products - Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
202518.55+£0
202518.55-£1.7M
2024152.63+£4.4M
20238.02-£438k
202277.27—

Derived from filed accounts. Not audited figures.